Skip to main content
. Author manuscript; available in PMC: 2014 Jul 18.
Published in final edited form as: Genes Immun. 2014 Mar 6;15(4):210–217. doi: 10.1038/gene.2014.6

Table 2.

Forward stepwise regression models for anti-Ro

Marker Estimates from the multiple regression model
Single marker
OR (95% CI) P-value Class Gene OR (95% CI) P-value
(A) Forward stepwise regression (BIC = 2826.1)
 rs3129962 (A<G) 2.44 (2.08–2.94) 9.47 × 10−27 Class III BTNL2 2.32 (1.98–2.71) 2.02 × 10 −25
 rs9271731 (A<G) 1.54 (1.30–1.85) 9.56 × 10−07 Class II DRB1-DQA1 1.27 (1.09–1.49) 2.58 × 10 −03
 rs3957146 (G<A) 0.52 (0.39–0.69) 5.70 × 10−06 Class II DQB1-DQA2 0.38 (0.29–0.50) 3.10 × 10 −12
(B) Forward stepwise regression beginning from Thr77 DRB1 (BIC =2815.9)
 Thr77 DRB1 0.49 (0.41–0.60) 2.72 × 10−13 Class II DRB1 0.45 (0.39–0.52) 5.26 × 10 −25
 rs9271731 (A<G) 1.63 (1.37–1.95) 4.50 × 10−08 Class II DRB1-DQA1 1.27 (1.09–1.49) 2.58 × 10 −03
 rs3130781 (G<A) 1.44 (1.22–1.71) 1.76 × 10−05 Class III DPCR1 1.95 (1.69–2..25) 2.19 × 10 −20
HLA-DQB1*03:02 0.56 (0.42–0.73) 2.49 × 10−05 Class II DQA1 0.42 (0.33–0.55) 1.67 × 10 −10
(C) Forward stepwise regression conditioning on HLA-DRB1*03:01 + HLA-DRB1*15:01 (BIC = 2829.8)
HLA-DRB1*03:01 2.22 (1.88–2.66) 1.11 × 10−20 Class II DRB1 2.22 (1.91–2.59) 9.29 × 10 −25
HLA-DRB1*15:01 1.54 (1.28–1.85) 4.11 × 10−06 Class II DRB1 1.32 (1.13–1.57) 7.42 × 10 −04
 rs9275582 (A<G) 0.61 (0.50–0.75) 2.99 × 10−06 Class II DQB1-DQA2 0.45 (0.38–0.55) 6.12 × 10 −16
(D) Forward stepwise regression analysing HLA alleles only (BIC =2829.6)
HLA-DRB1*03:01 2.38 (2.02–2.80) 1.21 × 10−25 Class II DRB1 2.22 (1.91–2.59) 9.29 × 10 −25
HLA-DRB1*15:01 1.63 (1.36–1.95) 9.71 × 10−08 Class II DRB1 1.32 (1.13–1.57) 7.42 × 10 −04
HLA-DQB1*03:02 0.53 (0.41–0.70) 4.84 × 10−06 Class II DQB1 0.42 (0.33–0.55) 1.67 × 10 −10
(E)Forward stepwise regression analysing amino acid data only (BIC =2827.2)
 Thr77 DRB1 0.29 (0.24–0.36) 4.00 × 10−32 Class II DRB1 0.45 (0.39–0.52) 5.26 × 10 −25
 Leu67 DRB1 0.64 (0.53–0.77) 2.81 × 10−06 Class II DRB1 1.05 (0.93–1.20) 4.22 × 10 −01
 Gln96 DRB1 1.47 (1.23–1.76) 2.29 × 10−05 Class II DRB1 1.29 (1.11–1.51) 1.28 × 10 −03

Abbreviations: BIC, bayesian information criterion; CI, confidence interval; HLA, human leukocyte antigen; OR, odds ratio; SNP, single-nucleotide polymorphism. SNPs have their minor and major alleles noted in brackets (A<G where A is the minor allele, for example), the OR is with respect to the minor allele. For BIC see Materials and Methods.

HHS Vulnerability Disclosure